Publications(FY 2016)

2015-01.

Eta M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S.
Japan RCC Trialist Collaborative Group (JRTCG) investigators.: Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
BMC cancer: 2015; 15(1):667. [5y-IF: 3.642]

2015-02.

Oura T, Hotta K, Cosimi AB, Kawai T.
Transient Mixed Chimerism for Allograft Tolerance.
Chimerism. 2015; 6(1-2):21-26. [5y-IF: -]

2015-03.

Mitsui T, Moriya K, Morita K, Iwami D, Kitta T, Kanno Y, Takada M, Shinohara N.
Risk Factors for Lower Urinary Tract Dysfunction and Symptoms After Successful Renal Transplantation. Ann Transplant.
2015; 20:757·763. [5y-IF: 1.069]

2015-04.

Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P; CheckMate 025 Investigators (Korbenfeld E, Palazzo FS, Recondo G, Chacon M, Richardet ME, Susana M, Pook D, Toner G, Gurney H, Davis I, Pittman KB, Kavina A, Schmidinger M, Loidl W, Scballier D, Machiels JP, Schoffslci P, Rottey S, Dzik C, Schutz F, Franke FA, Kollmannsberger CK, Heng D, Ifuox J, Wood L, Basappa N, Zalewski P, Ghedira S, Miller W, Melichar B, Kubala E, Prausova J, Donskov F, Jensen NY, Geertsen P, Bono P, Ravaud A, Escudier B, Chevreau C, Rolland F, Gravis G, Tourani JM, Geoffrois L, Oudard S, Heidenreich A, Imkamp F, Bedke J, Meiler J, Retz M, Goebell P, Pahernik S, Bamias A, Papazsis K, McCaffi.·ey JA, McDermott R, Neumann A, Berger R, Neiman V, Santoro A, Sternberg C, Roila F, Procopio G, Maio M, Bracarda S, De Giorgi U, Hongo F, Kimura G, Kanayama H, Kitamura H, Kume H, Uemura H, Yonese J, Tanabe K, Tatsugami K, Eto M, Oya M, Saito M, Uemura M, Yao M, Shinohara N,'Yamaguchi R, Fukasawa S, Kato T, Sugiyama T, Ohara W, Heinrich D, Straume O, Szcylik C, Slomian G, Wojcik·Tomaszewska J, Tomczak P, Zdrojowy R, Volovat C, Lungulescu D, Sinescu I, Poddubskaya E, Karlov P, Matveev V, Suarez C, Castellano D, Puente J, Arranz JA, Perez Gracia JL, Del Muro X, Jellvert A, Harmenberg U, Wagstaff J, Gore M, Nathan P, Eisen T, Alva A, Amin A, Carthon B, McDermott D, Quinn D, Vaena D, Lam E, Plimack E, Millard F, Quddus F, Beltran H, Drabkin H, Hammers HJ, Brngarolas J, Clark J, Hainsworth J, Sarantopoulos J, Sosman J, Beck JT, Fong L, Fishman M, Harrison M, Dawson N, Sharma P, Figlin R, Motzer R, George S, Srinivas S, Tykodi S, Kuzel T, Logan T, Olenclci T, Vaishampayan U, Voelzke W)
Nivolumab versus everolimus in advanced renal-cell carcinoma.
N Engl J Med. 2015; 373(19):1803· 1813. [5y-IF: 56.170]

2015-05.

Wada H, Kudo H, Baghdadi M, Seino K.
New immune regulation strategy in the age of regenerative medicine using pluripotent stem cells.
Inflammation & Regeneration. 2015; 35:238·243. [5y-IF: -]

2016-01.

Abe T, Sazawa A, Harabayashi T, Osishi Y, Miyajima N, Tsuchiya K, Maruyama S, Okada H, Shinohara N.
Laparoscopic resection of paraaortic/paracaval neurogenic tumors: surgical, outcomes and technical tips.
Surg Endosc. 2016; 30(10):4640·4645. [5y-IF: 3.499]

2016-02.

Abe T, Matsumoto R, Shinohara N.
Role of surgical consolidation in metastatic urothelial carcinoma.
Curr Opin Urol. 2016; 26(6):573·580. [5y-IF: 1.822]

2016-03.

Abe T, Ishizaki J, Kikuchi H, Minami K, Matsumoto R, Harabayashi T, Sazawa A, Mochizulci T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.
Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.
Urol Oncol. 2016; doi: 10.1016/j.urolonc.2016.08.016. [5y-IF: 2.739]

2016-04.

Abe T.
Editorial Comment to Use of sigmoid colon in orthotopic neobladder reconstruction: Long-term results.
Int J Urol. 2016; doi: 10.1111/iju.13222. [5y-IF: 1.932]

2016-05.

Brinkman CC, Iwami D, Hritzo MK, Xiong Y, Ahmad S, Simon T, Hippen KL, Blazar BR, Bromberg JS.
Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration.
Nat Commum. 2016; 7:12021. [5y-IF: 12.001]

2016-06.

Hotta K, Aoyama A, Oura T, Yamada Y, Tonsho M, Huh KH, Kawai K, Schoenfeld D, Allan JS, Madsen JC, Benichou G, Smith RN, Colvin RB, Sachs DH, Cosimi AB, Kawai T.
Induced regulatory T cells in allograft tolerance via transient mixed chimerism.
JCI insight. 2016; cloi: 10.1172/jci.insight.86419. [5y-IF: -]

2016-07.

Itoh S, Araki A, Mitsui T, Miyashita C, Goudarzi H, Sasaki S, Cho K, Nakazawa H, Iwasaki Y, Shinohara N, Nonomura K, Kishi R.
Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
Environ Int. 2016; 94:51-59. [5y-IF: 6.604]

2016-08.

Iwami D, Ogawa Y, Fujita H, Morita K, Sasaki H, Oishi Y, Higuchi H, Hatanaka K, Shinohara N.
Successful treatment with foscarnet for or ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
Nephrology. 2016; 21 Suppl 1:63·66. [5y-IF: 2.016]

2016-09.

Kitamura S, Hata H, Inamura Y, Imafuku K, Yanagi T, Oishi Y, Maruyama S, Shimizu H.
Chronic papillomatous dermatitis around an ileostoma.
J Dermatol. 2016; 43(2):220·221. [5y-IF: 1.948]

2016-10.

Kitta T, Chancellor MB, de Groat WC, Shinohara N, Yoshimura N.
Role of the anterior cingulate cortex in the control of micturition reflex in a rat model of Parkinson's disease.
J Urol. 2016; 195(5):1613-1620. [5y-IF: 4.169]

2016-11.

Kitta T, Mitsui T, Kanno Y, Chiba H, Moriya K, Yoshioka M, Shinohara N.
Differences in neurotransmitter systems of ventrolateral periaqueductal gray between the micturition reflex and nociceptive regulation: An in vivo microdialysis study.
Int J Urol. 2016; 23(7):593-598. [5y-IF: 1.932]

2016-12.

Kitta T.
Editorial comment about the efficacy of combination therapy involving 83-adrenoceptor stimulation and muscarinic acetylcholine receptor blockade in rats with overactive bladder.
Int J Urol 2016; 23(5):430. [5y-IF: 1.932]

2016-13.

Kitta T, Yabe I, Takahashi I, Matsushima M, Sasaki H, Shinohara N.
Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson's disease.
Int J Urol. 2016; 23(10):893·894. [5y-IF: 1.932]

2016-14.

Kon M, Saito K, Mitsui T, Miyado M, Igarashi M, Moriya K, Nonomura K, Shinohara N, Ogata T, Fukami M.
Copy Number Variations of the Azoospermia Factor Region and SRY Are Not Associated with the Risk of Hypospadias.
Sex Dev. 2016; 10(1):12·15. [5y-IF: 1.928]

2016-15.

Lal G, Kulkarni N, Nakayama Y, Singh AK, Sethi A, Burrell BE, Brinkman CC, Iwami D, Zhang T, Hehlgans T, Bromberg JS.
IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.
Immunol Lett. 2016; 170:52-63. [5y-IF: 2.453]

2016-16.

Matsumoto R, Tsuda M, Yoshida K, Tanino M, Kimura T, Nishihara H, Abe T, Shinohra N, Nonomura K, Tanaka S, Abe T, Shinohara N, Nonomura K, Tanaka S.
Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Sci Rep. 2016; doi: 10.1038/srep34625. [5y-IF: 5.525]

2016-17.

Matsumoto R.
Editorial Comment to "Risk stratification using Bmi-1 and Snail expression is a useful prognostic tool for patients with upper tract urothelial carcinoma."
Int J Urol 2016; doi: 10.1111/iju.13229. [5y-IF: 1.932]

2016-18.

Meng J, Jiang JJ, Atsumi T, Bando H, Okuyama Y, Sabharwal L, Nakagawa I, Higuchi H, Ota M, Okawara M, Ishitani R, Nureki O, Higo D, Arima Y, Ogura H, Kamimura D, Murakami M.
Breakpoint Cluster Region-Mediated Inflammation Is Dependent on Casein Kinase II.
J Immunol. 2016; pii: 1601082. [5y-IF: 5.287]

2016-19.

Mitsui T, ArakiA, Miyashita C, Ito S, Ikeno T, Sasaki S, Kitta T, Moriya K, Cho K, Morioka K, Kishi R, Shinohara N, Takada M, Nonomura K.
The Relationship between the Second-to-Fourth Digit Ratio and Behavioral Sexual Dimorphism in School-Aged Children.
PloS one. 2016; 11(1):e0146849. [5y-IF: 3.535]

2016-20.

Mitsui T, ArakiA, Goudarzi H, Miyashita C, Ito S, Sasaki S, Kitta T, Moriya K, Cho K, Morioka K, Kishi R, Shinohara N, Takada M, Nonomura K.
Effects of adrenal androgens during the prenatal period on the second to fourth digit ratio in school-aged children.
Steroids. 2016; 113:46·51. [5y-IF: 2.491]

2016-21.

Mitsui T, Kanno Y, Kitta T, Moriya K, Nonomura K.
Supraspinal Projection of Serotonergic and Noradrenergic Pathways Modulates Nociceptive Transmission in the Lower Urinary Tract of Rats.
Low Urin Symptoms. 2016; 8(3):186-190. [5y-IF: 0.305]

2016-22.

Moriya K, Nakamura M, Nishimura Y, Kitta T, Kanno Y, Chiba H, Kon M, Shinohara N.
Factors affecting post-pubertal penile size in patients with hypospadias.
World J Urol. 2016; 34(9):1317-1321. [5y-IF: 2.457]

2016-23.

Moriya K, Nakamura M, Nishimura Y, Kitta T, Kanno Y, Chiba H, Kon M, Shinohara N.
Long-term impact of unilateral hypo/dysplastic kidney in infants with primary vesicoureteral reflux.
J Pediatr Urol. 2016; doi: 10.1016/j.jpurol.2016.02.015. [5y-IF: 1.279]

2016-24.

Nakamura A, Iwami D, Miyoshi H, Morita K, Taguri M, Terauchi Y, Shinohara N, Atsumi T.
Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance.
Diabet Med. 2016; doi: 10.1111/dme.13199. [5y-IF: 3.306]

2016-25.

Osawa T, Hafez KS, Miller DC, Montgomery JS, MOl'gan TM, Palapattu GS, Weizer A'l, Caoili EM, Ellis JH, Kunju LP, Wolf JS Jr.
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk-Stratification Algorithm Based on Percutaneous Renal Mass Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
J Urol. 2016; 195(3):574·580. [5y-IF: 4.169]

2016-26.

Osawa T, Hafez KS, Miller DC, Montgomery JS, Morgan TM, Palapattu GS, Weizer NZ, Caoili EM, Ellis JH, Kunju LP, Wolf JS Jr.
Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Versus Malignant Disease and Low- Versus High-Risk Renal Tumors.
Urology; 2016; doi: 10.1016/j.urology.2016.05.044 [5y-IF: 2.241]

2016-27.

Osawa T, Lee CT, Abe T, Takada N, afez KS, Montgomery JS, Weizer AZ, Hollenbeck BK, Skolarus TA, Murai S, Shinohara N.
A Multi-Center International Study Assessing the Impact of Differences in Baseline Characteristics and Perioperative Care Following Radical Cystectomy.
Bladder Cancer. 2016; 2(2):251·261. [5y-IF: -]

2016-28.

Osawa T, Wittmann D, Jimbo M, Keller ET, Namiki S, Abe T, Shinohara N. Skolarus TA.
Providing prostate cancer survivorship care in Japan: Implications from the USA care model.
IntJ Ui'Di. 2016; doi: 10.1111/iju.13186. [5y-IF: 1.932]

2016-29.

Oura T, Ko DS, Boskovic S, O'Neil JJ, Chipashvili V, Koulmanda M, Hotta K. Kawai K, Nadazdin O, Smith RN, Cosimi AB, Kawai T.
Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Cell transplant. 2016; 25(7):1331·1341. [5y-IF: 3.366]

2016-30.

Oura T, Hotta K, Lei J, Markmann J, Rosales I, Dehnadi A, Kawai K, Ndishabandi D, Smith RN, Cosimi AB, Kawai T.
Immunosuppression with CD40 Costimulatory Blockade plus Rapamycin for Simultaneous Islet and Kidney Transplantation in Nonhuman Primates.
Am J transplant. 2016; doi: 10.1111/ajt.13999. [5y-IF: 5.637]

2016-31.

Shinohara N.
Editorial Comment to Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up.
Int J Urol. 2016; 23(1):40·41. [5y-IF: 1.932]

2016-32.

Wang Z, Pratts SG, Zhang H, Spencer PJ, Yu R, Tonsho M, Shah JA, Tanabe T, Powell HR, Huang CA, Madsen JC, Sachs DH, Wang Z.
Treg depletion in non-human primates using a novel diphtheria toxin-based anti-human CCR4 immunotoxin.
Mal Oneal. 2016; 10(4):553·65. [5y-IF: 6.080]

2016-33.

Xiong Y, Ahmad S, Iwami D, Brinkman CC, Bromberg JS.
T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function.
J Immunol. 2016; 196(6):2526·2540. [5y-IF: 5.287]

Page Top